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A B S T R A C T
Background and objectives: Swine vesicular disease virus (SVDV) is a close relative of the human
Enterovirus B serotype, coxsackievirus B5. As the etiological agent of a significant emergent veterinary
disease, several studies have attempted to explain its origin. However, several key questions remain,
including the full biological ancestry of the virus, and its geographical and temporal origin.
Methodology: We sequenced near-complete genomes of 27 SVDV and 13 coxsackievirus B5 samples, all
originally isolated between 1966 and 2006, and analysed these in conjunction with existing sequences
and historical information.
Results: While analyses incorporating 24 additional near-complete SVDV genomic sequences indicate
clear signs of within-SVDV recombination, all 51 SVDV isolates remain monophyletic. This supports a
hypothesis of a single anthroponotic transfer origin. Analysis of individual coding and non-coding
regions supports that SVDV has a recombinant origin between coxsackievirus B5 and another
Enterovirus B serotype, most likely coxsackievirus A9. Extensive Bayesian sequence-based analysis of
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the time of the most recent common ancestor of all analysed sequences places this within a few years
around 1961. Epidemiological evidence points to China as an origin, but there are no available samples
to test this conclusively.
Conclusions and implications: Historical investigation and the clinical aspects of the involved
Enterovirus B serotypes, makes the current results consistent with a hypothesis stating that SVDV
originated through co-infection, recombination, and a single anthroponotic event, during large viral
meningitis epidemics around 1960/1961 involving the ancestral serotypes. The exact geographical ori-
gin of SVDV may remain untestable due to historical aspects.
K E Y W O R D S : emerging diseases; RNA viruses; Enterovirus B; viral meningitis; SVDV; Picornaviridae
INTRODUCTION
Swine vesicular disease virus (SVDV) is the etiolo-
gical agent of swine vesicular disease (SVD) [1,2].
SVDV was initially isolated at two farms in
Lombardy, Italy, in October 1966, where due to
similarities in the symptoms of the affected swine,
an initial diagnosis of foot-and-mouth disease
(FMD) was made [1]. However, laboratory testing
failed to support this diagnosis, and ultimately lead
to the discovery of SVDV, and confirmation that it
was the agent of the disease [1,2]. SVDV is a single-
stranded (non-segmented) positive-sense RNA
virus [3], typically of around 7400 bases, and classi-
fied as a member of the Enterovirus B species (family
Picornaviridae). Although a pathogen of swine,
previous studies have noted close similarity in the
capsid region to another Enterovirus B serotype,
coxsackievirus B5 (CV-B5)—an observation that is
notable due to its status as a human pathogen linked
to a range of cardiovascular and neurological
pathologies [4–7]. Given this tantalising link, and
in particular the suggestion that SVDV may have
originated as an anthroponotic transfer (i.e. human
to swine), several studies have previously attempted
to identify the geographical, temporal, and biolo-
gical origin of SVDV [7,8]. In this regard, Hong
Kong has been postulated as the origin of SVDV,
given it was (i) the second location in which SVDV
was detected (in 1970), (ii) data support SVDV en-
demism in Hong Kong in subsequent years
(Supplementary Table S1, showing SVDV geograph-
ical occurrence) and (iii) several lines of evidence
indicate that SVDV has been introduced to Europe
from Asia in separate events after 1970 [8]. Time-
calibrated phylogenetic analyses of sequence data
from both structural [1D (VP1)] and non-structural
[3BC (VPg-protease)] regions of the genome, indi-
cate that SVDV is monophyletic with respect to other
serotypes, and had a last common ancestor between
1945 and 1965 [8]. Whether this date represents a
time-window for the original anthroponotic transfer
that lead to the establishment of SVDV in swine, or a
severe bottleneck in a longer history of the virus is
uncertain [8].
Complications exist, however, with the results of
the previous studies. It has previously been dis-
cussed that SVDV and CV-B5 are either homologous
across the genome, or only homologous in the cap-
sid region (due to recombination), or that their simi-
larity in the capsid region stems from convergent
evolution [8]. Enterovirus B serotypes are notoriously
recombinant viruses [9–11] and this fact has made it
difficult to determine the ancestral lineage of SVDV
outside the capsid region, regardless of whether one
assumes recombination as a part of its origin or not.
Because the external parts of the structural capsid
region (P1 region: 1A (VP4) (internal), 1B (VP2) (ex-
ternal), 1C (VP3) (external), 1D (VP1) (external)) de-
termine serology [4], analyses of this region will
generally be expected to reveal taxa of the same sero-
types as monophyletic [11,12]. However, this is not
the case for the non-structural regions [P2 region:
2A, 2B, 2C. P3 region: 3A, 3B (VPg), 3C (protease),
3D (polymerase)], where monophyly of serotypes is
typically only seen when the samples have a close
spatiotemporal relationship [12]. This greatly com-
plicates inference regarding the origin of SVDV—not
only for the non-structural regions.
To address these challenges, we generated near-
complete genome length sequences from a tempor-
ally distributed dataset of 27 SVDV and 13 CV-B5
isolates, and used this data to perform independent
phylogenetic analyses on eight protein-coding re-
gions and one non-coding region [the five prime un-
translated region (50UTR)] in order to assess both
the biological and the geographical origin of SVDV
across the full genome. Furthermore, we
investigated the occurrence of within-SVDV recom-
bination, and used the results to guide optimal
Bayesian inference dating estimates of the most
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recent common ancestor of all existing full or
near-full length sequenced SVDV strains. We subse-
quently placed these results in an Enterovirus
epidemiological and historical setting in order to
formulate a comprehensive, new and falsifiable hy-
pothesis on the origin of SVDV. This integrated ap-
proach sheds further light on the dynamics involved
when a pathogen emerges as the cause of a new
disease via a cross species transfer, in this case an
anthroponotic transfer to swine.
METHODOLOGY
Virus isolates selected
26 SVDV and 13 CV-B5 isolates grown in a pig kidney
cell line (IB-RS-2) were selected for near-complete
genome sequencing on the Illumina HiSeq platform,
an additional SVDV isolate (HKN/19/70) was
sequenced subsequently on the Illumina MiSeq plat-
form, for a total of 27 SVDV isolates (Table 1 and
Supplementary Table S4, for an overview of isolates
included in this study). Isolates were chosen (within
availability) to best reflect the known natural history
of SVD. CV-B5 isolates were chosen with the goal of
finding sequences closer related to SVDV, than
those, which are already known. All isolates were
obtained from The Pirbright Institute, UK, where
they have been held as a result of past veterinary
investigation into SVDV infected livestock.
RNA isolation, first-strand cDNA synthesis and
PCR amplification
RNA was extracted using an RNeasy kit (Qiagen,
Valencia, CA) followed by 1st strand cDNA synthesis
using SuperScript III Reverse Transcriptase,
RNaseOUT, and dNTPs (all Invitrogen, Carlsbad,
CA). All components were mixed and briefly
centrifuged before use. The following reagents were
mixed in a 0.2 ml PCR tube at a total of 12 ml: 5 ml
RNA, 2 mM oligo(dT) primer and 0.4 mM dNTPs.
Samples were incubated 5 min at 65C followed by
a snap-chill on ice. To the RNA/primer/dNTP mix
the following reagents were added to a total of 20
ml: 1 RT buffer, 10 mM DTT, 40 U RNaseOUT and
200 U SuperScript III RT enzyme. After a gentle mix
and brief centrifugation samples were incubated
50 min at 50C followed by 15 min at 70C. To each
sample, 1 ml RNase H was added, incubated for
20 min at 37C, and transferred to ice. PCR amplifi-
cation was performed as previously published [13].
Sample fragmentation and preparation for
export from the Pirbright laboratory
DNA concentration was quantified using a ND-1000
spectrophotometer (NanoDrop Technologies,
Thermo Scientific, Wilmington, DE) prior to frag-
mentation using NEBNext dsDNA Fragmentase
(New England Biolabs, Ipswich, MA).
Fragmentation was performed as follows: 3 mg
DNA from each sample was added to 1
Fragmentase Reaction buffer, 1 BSA, and
nuclease-free water ad hoc to 54 ml. The reaction
mix was subsequently vortexed thoroughly and
incubated on ice for 5 min. Three units of dsDNA
Fragmentase were added to the reaction and
incubated 15 min at 37C in order to generate frag-
ments sizes of 600–800 bp. The incubation was
stopped by addition of 5 ml 0.5 mM EDTA. Samples
were purified using Qiagen’s PCR purification kit
(Qiagen, Valencia, CA) according to manufacturer’s
guidelines. Samples were eluted in 30 ml EB buffer.
Correct fragment sizes were verified on the Agilent
2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA) using a DNA7500 chip. Prior to sample
export, 1/10 volume of sodium acetate (3M) was
added as well as 2.5 volumes of absolute ethanol
(calculated after addition of sodium acetate).
Samples were incubated for 2 h at 56C and washed
with disinfectant (FAM 30; Evans Vanodine
International plc, Preston, UK).
Ethanol precipitation
Amplicons from Pirbright containing sodium acet-
ate and absolute ethanol were centrifuged at
14 000 g for 1 h at 4C. Supernatant was carefully
removed and discarded, leaving a DNA pellet.
Pellets were dissolved and rinsed in 150 ml ice-cold
ethanol (70%) and afterwards centrifuged again for
15 min. Supernatant was discarded and pellet was
dried for 10 min at 65C before being dissolved in 85
ml EB buffer.
High-throughput deep sequencing
Samples were fragmented further to meet the
desired insert size for sequencing on the Illumina
platform, using the Bioruptor Sonication System
(Diagenode, Denville, NJ) with the setting: High in-
tensity, 3000/3000, 20 cycles. Resulting fragment sizes
were analysed using a High Sensitivity chip on the
Agilent 2100 Bioanalyzer.
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Table 1. Samples sequenced in this study
Sample no. Virus Isolate reference Origin Date collected Accession no.
1 SVDV BUL/2/71 Plovdiv, Bulgaria 1971 KT284979
3 SVDV GRE/1/79 Greece July 1979 KT284980
6 SVDV UKG/308/73 Farm H, Heaton Moor, Stockport, Gtr.
Manchester, UK
30 October 1973 KT284981
8 SVDV USS/6/72 Odessa region, Ukraine, USSR 1972 KT284982
10 SVDV HKN/1/80 Tai Shui Hang, Lantau Island, Hong Kong 1 February 1979 KT284983
11 SVDV HKN/7/81 Bing Kong, Sheung Shui, N.T., Hong Kong 6 January 1981 KT284984
12 SVDV HKN/1/82 Shek Kong, Kam Tin, N.T., Hong Kong 2 April 1981 KT284985
13 SVDV HKN/5/85 Ping Che, Ta Kwu Ling, Fanling, N.T.,
Hong Kong
28 December 1984 KT284986
14 SVDV HKN/19/85 Mong Tseng Tsuen, Ping Shan, Y.L., N.T.,
Hong Kong
3 July 1985 KT284987
15 SVDV HKN/12/87 Ma Tso Lung, Sheung Shui, N.T.,
Hong Kong
25 March 1987 KT284988
16 SVDV MTA/22/75 Rabat, Zebbug, Malta 20 August 1975 KT284989
17 SVDV ITL/A/89 Campodoro, Padova, Veneto, Italy 23 December 1988 KT284990
18 SVDV ITL/1/91 Messina, Sicily, Italy 30.January 1991 KT284991
19 SVDV ITL/2/91 Agerola, Naples, Campania, Italy 15 April 1991 KT284992
21 SVDV ITL/16/2006 Offlaga, Brescia, Lombardy, Italy 1 December 2006 KT284993
22 SVDV AUR/1/73 Wiener Neustadt, Austria December 1972 KT284994
23 SVDV POL/1/73 Yaslo District, Poland 13 December 1972 KT284995
24a SVDV HKN/19/70 Kwan Tei, Fanling, N.T., Hong Kong 9 March 1970 KT284996
25 SVDV ITL/1/66 Lombardy, Italy October 1966 KT284997
26 SVDV HKN/36/71 Shui Tsan Tin, Pat Heung, Y.L., Hong Kong 29 April 1971 KT284998
28 SVDV FRA/1/73 Bordeaux, France January 1973 KT284999
29 SVDV HKN/11/72 Ngau Tam Mei, Sun Tin, N.T., Hong Kong 29 February 1972 KT285000
31 SVDV HKN/3/91 Fung Kut Heung, Kam Tin, Y.L., N.T.,
Hong Kong
6 July 1991 KT285001
32 SVDV HKN/4/89 Ki Lun Shan, San Tin, Y.L., N.T.,
Hong Kong
19 March 1989 KT285002
33 SVDV TAW/119/97 Kaoshiung, Taiwan POC 18 December 1997 KT285003
36 SVDV ITL/3/73 Latina, Lazio, Italy November 1972 KT285004
37 SVDV ITL/5/77 Mantova, Lombardy, Italy 3 October 1977 KT285005
40 CV-B5 2137/70 Wisconsin, USA 1970 KT285006
41 CV-B5 4469/72 Georgia, USA 1972 KT285007
42 CV-B5 9030/77 Idaho, USA 1977 KT285008
43 CV-B5 4634/83 Alabama, USA 1983 KT285009
44 CV-B5 9954 Birmingham, UK 1973 KT285010
45 CV-B5 8068 Birmingham, UK 1973 KT285011
46 CV-B5 1603/Finland/82 Finland 1982 KT285012
48 CV-B5 93083-3/Taiwan/83 Taiwan 1983 KT285013
49 CV-B5 028/Pakistan/91 Pakistan 1991 KT285014
50 CV-B5 93-17428/France/93 France 1993 KT285015
51 CV-B5 84-6500/France/84 France 1984 KT285016
53 CV-B5 4267/Cambridge/92 Cambridge, UK 1992 KT285017
54 CV-B5 HONGKONG Hong Kong c. 1972 KT285018
aThis sample was sequenced on the Illumina MiSeq platform, all other samples were sequenced on the Illumina HiSeq platform (see ‘Methodology’
section).
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Independent sequencing libraries were produced
on each sample using New England Biolabs’
NEBNext DNA Sample Prep, Master Mix Set 2.
Samples were subsequently pooled and sequenced
on 2 lanes of an Illumina HiSeq2000 (100SR).
Processing of raw data and sequence assembly
Using AdapterRemoval (at the time of application the
program was called SinglEndPrimeRemoval3-5M) [14]
raw sequence reads were trimmed if they contained
N’s, had a Phred Sanger score <35, or if the adapter
sequence aligned to the read using default settings.
Reads shorter than 25 bps were also removed. The
cleaned sequences were checked with FastQC [15] fol-
lowed by removal of duplicates using PRINSEQ [16].
Processed reads were mapped using a workflow
described previously [17], but adjusted to the high
number of reads obtained from the Illumina HiSeq
platform (unique read numbers ranged from
465 568–4 727 739 per isolate). De novo assembly
was only used for an initial assessment of the work-
flow on the data set. Final consensus sequences were
obtained by using three different iterative mappings
for all isolates (except HKN/19/70, see below), the
first with SVDV acc. X54521 isolate UKG/27/72 as the
reference, using the standard ‘Medium Sensitivity’
setting in Geneious 6.0.3 [18] and allowing up to 25
iterations, the second mapping was against the same
reference but using the standard ‘Low Sensitivity’
setting and allowing up to 100 iterations. Finally iso-
late reads were mapped with CV-B5 acc. X67706 iso-
late 1954/UK/85 as the reference, using the ‘Medium
Sensitivity’ setting and up to 25 iterations (some of
these mappings were allowed to run for up to 100
iterations, depending on mapping convergence).
The consensus sequences were obtained using a
strict 50% criterion for the base-calls. The final con-
sensus sequence for each isolate was then obtained
by aligning the consensus sequences for each of the
three mappings and calling the bases using a 100%
strict criterion (in a few cases, a mapping consensus
was left out of this final alignment due to obvious
error in the parent contig). Three of these samples
(CV-B5/93083-3/Taiwan/83; CV-B5/028/Pakistan/
91; CV-B5/93-17428/France/93) were additionally
de novo assembled using DNAstar SeqMan NGen
version 12 [19]. The processed fastq files were
sampled using 200 000 reads. The following param-
eters were: GenomeLength: 7000; MaxGap: 6;
MatchSize: 21; MatchSpacing: 50; and
MinMatchPercent: 93. In each case a full-length
contig was generated and exported as a fasta file.
The relevant fasta file was then used as a template
to examine the whole fastq dataset in a templated
assembly using the same software. Depth of cover-
age was generally between 10 000 and 20 000. This
was done to assess the occurrence of a few degener-
ate calls within these sequences using the former
method (degeneracies were included in analyses).
The isolate HKN/19/70 was sequenced on the
Illumina MiSeq Platform (150 bases/paired end/
Nextera XT) and de novo assembled using DNAstar
SeqMan NGen version 11.2.1 [19].
Trimming sequences within the primers left them
with a norm length of 6983 bp, including the entire
coding region and a further 307 bases upstream and
73 bases downstream (excluding stop codon).
Recombination analysis
Within-SVDV recombination analysis was performed
by aligning the 27 SVDV sequences from this study
with those from all 24 existing SVDV isolates having
complete or near-complete genome length se-
quences available (Table 1 and Supplementary
Table S4). Alignment was performed with the
MAFFT v. 7.017 [20,21] plug-in in Geneious 6.0.3
[18] with subsequent visual inspection and minor
manual editing, leaving the 51 sequence alignment
7412 bases long. This basic SVDV alignment (BSA)
was then used to construct a set of derived align-
ments either non-randomly (by selection a genome
section and extracting this) or pseudo-randomly (by
reducing the number of sequences in the alignment),
or in a few cases by a combination of the above, for a
total of 15 alignments (Supplementary Table S2). All
alignments were run in GARD [22,23] on the server
provided by www.datamonkey.org [24] (29 December
2013, date last accessed), either to convergence or to
the maximum server allowance cut-off. A single gen-
ome-wide plot was then constructed showing all re-
combination signals detected across all 15 analyses
and their levels of support (Kishino-Hasegawa [25])
(Supplementary Fig. S1).
Phylogenetic analysis of genomic sections
To determine the closest related (sequenced) virus
strains to SVDV across the genome, the BSA was
used to obtain 9 further derived alignments, corres-
ponding exactly to the following genomic sections:
50UTR, 1A (VP4), 1B (VP2), 1C (VP3), 1D (VP1), 2A,
2C, 3C (protease), 3D (polymerase). For each of
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these alignments all 51 taxa were compared against
Genbank [26] entries using BLAST [27] under stand-
ard settings, except that sequences with taxon ID:
12075 [SVDV] were excluded, and that for each align-
ment the number of sequences retained from each
query was adjusted to either 10, 50 or 100 depending
on an ad hoc assessment of the number of closely
related sequences in the database for that particular
region. This was done to exclude very distant se-
quences from the analysis. For each of the nine sec-
tions, BLAST [27] results from all 51 taxa were
downloaded, duplicates with respect to accession
number were removed, but duplicate sequences were
left (to avoid inadvertent removal of entries with su-
perior annotations), short matches were also
removed, with a cut off of 150, 200 or 250 bases de-
pending on the section. The BLAST [27] hits were
aligned with the queries and with the corresponding
sequence section from the 13 CV-B5 isolates
sequenced in this study (and 3 further CV-B5 isolates
previously sequenced but suspected of contamin-
ation). Alignment was performed using the same
methodology as for the recombination analysis,
(Supplementary Table S5). All alignments were
tested in jModelTest v. 2.1.1 [28,29] allowing 4
gamma categories, invariant sites and unequal
frequencies under 11 different substitution schemes.
They were assessed under the Akaike [30], corrected
Akaike [31] and Bayesian information [32] criteria
(AIC, AICc and BIC) as well as the decision theoretic
performance-based selection criterion (DT) [33]. For
situations yielding differing results across criteria the
BIC and DT were adhered to. BIC and DT were in
accord across all analyses (Supplementary Table
S5). The chosen model (for each alignment) was im-
plemented for maximum likelihood based phylogen-
etic tree construction in GARLI v 2.0 [34] using three
search replicates. Branch supports (aBayes [35]) were
obtained in PhyML v. 20110526 [36] by fixing the top-
ology, and parameters obtained from the best search
replicate in GARLI, but with allowance for branch
length optimization; except for the 3C alignment
where a separate bootstrap run (100) was performed
in GARLI and annotated onto the best search repli-
cate using TreeAnnotator v. 1.8.0 [37]. All 9 trees were
visualized using FigTree v. 1.4.0 [38] (Fig. 1 and
Supplementary Fig. S2).
Bayesian dating estimates
Timing of events in the SVDV phylogeny was
estimated using a Bayesian statistical approach, as
implemented in the BEAST v.1.8.0 package [37]. The
51 taxa full length BSA was assigned tip dates ac-
cording to the time of sample collection. Isolates
lacking a precise date were coded with the ‘set pre-
cision’ function in BEAUti v. 1.8.0. [37] (e.g. when the
date was given as a month in a year, the first of that
month was entered as date with a forward ‘precision’
of 0.083). Two alignments extracted from this dated
BSA were then constructed, corresponding to two
different sections of the genome based on the re-
sults from the recombination analysis
(Supplementary Fig. S1 and Supplementary Table
S2). One from within the 1C (VP3) to 1D (VP1) sec-
tion (400 full codons, positions 1881–3080 in SVDV
H/3’76 D00435) and the other spanning the entire
3C (protease) to 3D (polymerase) region (645 full
codons). These were analysed under five different
tree priors (4 coalescent [39–42], and an epidemio-
logical birth-death prior [43]) and using 3 different
molecular clocks [44,45]. For a total of 30 analyses
(Table 2)). All analyses were run under the SRD06
model of sequence evolution [46]. All analyses ran
for 40 000 000 steps, sampling every 4000 [40]. All
parameters for all analyses converged, and the min-
imum ESS value for any parameter in any run was>
200, as assessed by using Tracer v.1.5 [47] with a
burn-in of 10%. Path Sampling (PS) [48,49] and
Stepping-Stone (SS) [50] analyses were performed
for all analyses to establish marginal likelihoods
[51], using 64 steps and a chain length of 1 000
000, sampling every 100 (Table 2). Trees for the
analyses with the highest marginal likelihood for
each section and for both coalescent and epidemio-
logical birth-death tree priors (for a total of 4, (in
bold, Table 2)) were summarized in TreeAnnotator
v.1.8.0 [37], using the maximum clade credibility
criteria, a posterior probability limit of zero, median
heights and a burn-in of 10%, and visualized in
FigTree v.1.4.0 [38] (Supplementary Fig. S3). Priors
used in the analyses can be found in Supplementary
Table S6.
RESULTS
Recombination analysis
Within-SVDV recombination analysis was con-
ducted to ascertain which genomic regions were free
of recombination signals, and thus suitable for use
in the Bayesian dating estimates analyses. Of the 15
recombination analyses performed to ensure
increased detection sensitivity and for lowering the
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Figure 1. Maximum likelihood tree for the 3D (Polymerase) genomic section
Result from the maximum likelihood phylogenetic analysis of the 3D (Polymerase) genomic section (see also Supplementary
Table S5 and Methodology). Showing—on top—an unrooted tree with no taxa designations, except that branches leading to an
SVDV isolate are coloured pink, and closest related samples are shown in orange (Dutch CV-A9 samples) and blue (Greek
echovirus serotype E14 samples), giving an immediate overview of the relation between SVDV and all other sequences in the
analysis, including relative (and if conferring with the 0.1 substitution-per-site bar, also absolute) distance to the nearest neigh-
bours. Below, a cut-out of a mid-point rooted versions of the same tree. The earliest SVDV isolate (ITL/1/66) is seen as sister to all
other SVDV isolates at the root of the monophyletic SVDV cluster. The early Dutch, 1963, CV-A9, isolate (Net/1/63 acc. AF224653)
is seen as a strongly supported sister of all SVDV sequences (0.92 aBayes [35])
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Table 2. Bayesian dating estimates
Alignment Partial capsid alignment. 400 codons
within 1C-1D (VP3-VP1). SRD06 codon
partition model for nucleotide substitution
Full Protease 3C—Polymerase 3D
alignment. 645 codons. SRD06 codon
partition model for nucleotide substitution
Tree prior Molecular Clock Marginal likelihood
[log(10) values]
Age of root [Decimal
calendar years]
Marginal likelihood
[log(10) values]
Age of root [Decimal
calendar years]
SS Mean/Median
(95% HPD)
SS Mean/Median
(95% HPD)
PS PS
SS–PS SS–PS
SS-best–SS-current SS-best–SS-current
Coalescent
Constant Size
Strict 6175.92769 1961.55/1961.50 9239.50417 1959.22/1959.27
6176.26690 (1959.73–1963.23) 9239.93468 (1957.16–1961.06)
0.3392 0.4305
57.1 78.0
Uncorrelated
Lognormal
Relaxed
6124.19152 1957.80/1958.58 9166.40662 1954.50/1955.53
6124.49187 (1949.90–1963.81) 9166.66545 (1943.79–1962.64)
0.3002 0.2588
5.33 4.94
Uncorrelated
Exponential
Relaxed
6125.13136 1955.57/1957.32 9163.73276 1952.42/1954.68
6125.56094 (1942.13–1964.72) 9164.14054 (1935.18–1963.58)
0.4296 0.4078
6.27 2.27
Coalescent
Exponential
Growth
Strict 6173.90996 1961.48/1961.53 9240.11241 1959.22/1959.27
6174.26098 (1959.74–1963.26) 9240.88384 (1957.29–1961.15)
0.3510 0.7714
55.1 78.6
Uncorrelated
Lognormal
Relaxed
6124.85464 1957.50/1958.23 9164.29592 1954.60/1955.63
6125.06475 (1949.74–1963.92) 9164.84035 (1944.27–1962.99)
0.2101 0.5444
6.00 2.83
Uncorrelated
Exponential
Relaxed
6124.24950 1953.77/1956.00 9164.85397 1951.49/1953.92
6124.32176 (1937.57-1964.22) 9165.35887 (1934.12–1963.94)
0.0722 0.5049
5.39 3.39
Coalescent
Logistic
Growth
Strict 6178.50005 1961.53/1961.60 9240.90492 1959.26/1959.29
6178.82343 (1959.67–1963.18) 9241.40787 (1957.29–1961.21)
0.3234 0.5030
59.6 79.4
Uncorrelated
Lognormal
Relaxed
6126.80959 1957.89/1958.67 9167.96309 1954.19/1955.30
6126.91267 (1949.95–1964.05) 9168.60143 (1943.54–1962.95)
0.1031 0.6383
7.95 6.50
Uncorrelated
Exponential
Relaxed
6127.11748 1955.48/1957.15 9166.95847 1953.06/1954.82
6127.66222 (1941.97–1964.45) 9166.96760 (1938.69–1963.67)
0.5447 0.00913
8.26 5.49
(continued)
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risk of genomic regions being falsely negative for
recombination signals (Supplementary Table S2
and Supplementary Fig. S1), all except numbers 7
and 8 (which are both limited to genome region P3
and the 30UTR) yielded signals of recombination.
Recombination signals were distributed non-
randomly across analyses and the genome. Several
recombination signals did not pass the Kishino-
Hasegawa [25] test for significance. This included
one located at the transition between the highly
conserved internal ribosome entry site and the
hyper-variable spacer region [52] in the 50UTR
(genome position approximately 570, SVDV H/376
D00435), and a second at approximately position
818, which is roughly one third into the short 1A
(VP4) protein coding region. Highly supported sig-
nals are found at both the beginning and the end of
the 1B (VP2) protein coding region; towards the last
quarter of 1D (VP1); within 2A; possibly within the
middle of 2C; and finally in 3A. The alignment is free
of recombination signals downstream of just prior to
the start of 3C. This combined information was used
to select two genomic sections free of recombin-
ation signals for subsequent dating analysis, one
from within the 1C (VP3) to 1D (VP1) section (400
full codons, positions 1881–3080 in SVDV H/3076
D00435) and the other spanning the entire 3C (pro-
tease) to 3D (polymerase) region (645 full codons).
Table 2. Continued
Alignment Partial capsid alignment. 400 codons
within 1C-1D (VP3-VP1). SRD06 codon
partition model for nucleotide substitution
Full Protease 3C—Polymerase 3D
alignment. 645 codons. SRD06 codon
partition model for nucleotide substitution
Coalescent
Bayesian
Skyline
Strict 6167.89123 1961.85/1961.91 9228.88172 1959.47/1959.52
6168.16191 (1960.05–1963.48) 9229.35113 (1957.55–1961.37)
0.2707 0.4694
49.0 67.4
Uncorrelated
Lognormal
Relaxed
6118.85855 1960.25/1960.84 9161.46459 1957.44/1958.14
6119.00140 (1954.35–1965.23) 9161.45594 (1949.51–1964.11)
0.1429 0.0087
0.00 0.00
Uncorrelated
Exponential
Relaxed
6121.10564 1958.81/1960.49 9162.02247 1957.90/1959.32
6121.26521 (1947.82–1965.90) 9162.18815 (1947.02–1965.23)
0.1596 0.1657
2.25 0.56
Epidemiology
Birth-Death
Basic
Reproductive
Number
Strict 6169.06252 1962.06/1962.11 9233.63644 1959.80/1959.85
6169.64219 (1960.471963.67) 9234.08112 (1957.96–1961.56)
0.5797 0.4447
50.2 72.2
Uncorrelated
Lognormal
Relaxed
6120.52255 1962.65/1962.85 9163.50126 1961.42/1961.65
6120.90851 (1959.68–1965.39) 9164.01821 (1957.89–1964.73)
0.3860 0.5170
1.66 2.04
Uncorrelated
Exponential
Relaxed
6121.87552 1963.02/1963.26 9163.38768 1962.38/1962.63
6122.19743 (1959.90–1965.66) 9163.73844 (1959.06–1965.27)
0.3219 0.3508
3.02 1.92
Timing of events in the SVDV phylogeny estimated using a Bayesian statistical approach. The 51 taxa full-length basic SVDV alignment (BSA) was
assigned tip dates according to the time of sample collection. Two alignments extracted from this dated BSA were then constructed, corresponding to
two different sections of the genome based on the results from the recombination analysis—one from within the 1C (VP3) to 1D(VP1) section (400 full
codons, positions 1881–3080 in SVDV H/3076 D00435) and the other spanning the entire 3C (protease) to 3D (polymerase) region (645 full codons).
These were analysed under five different tree priors using three different molecular clocks. All analyses were run under the SRD06 model of sequence
evolution [46]. PS [48,49] and SS [50] analyses were performed for all analyses to establish marginal likelihoods [51]. Highest marginal likelihood results
for each section and for both coalescent and epidemiological birth-death tree priors are shown in bold (see also Supplementary Fig. S3 and
Methodology).
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Phylogenetic reconstruction of genomic
sections
SVDV sequences were monophyletic in eight of the
nine genomic subsections analysed (Fig. 1 and
Supplementary Fig. S2). The final analysis, 1A
(VP4), is based on the shortest alignment (207
bases), and it is noteworthy that some of the se-
quences which break the monophyly are also among
those found to be closest to SVDV in the other capsid
region analyses. For the 50UTR there is a long branch
leading to the SVDV cluster, and there are no
sequences distinctly closest to the cluster. The
sequences in that particular analysis are distin-
guished by being from a very diverse set of
Enterovirus B viruses, but with only very few CV-B5
isolates (relative to capsid region analyses).
Overall, the largest sequence dataset that we
could compare our results to was the one for gen-
omic region 1D (VP1). In this regard, the phylogen-
etic association recovered is in agreement with that
published by Gullberg et al. (2010) [53], and the
SVDV cluster falls within the CV-B5 subgenogroup
A1 following the nomenclature of Henquell et al.
(2013) [54]. Within this cluster we also placed CV-
B5 sequences from Taiwan, Japan and Belarus, in
addition to the geographically diverse cluster of se-
quences from [South] Korea, Romania, Germany,
Netherlands, France, Denmark and China that were
previously placed there by Henquell et al. (2013) [54].
Generally, for all three external capsid regions [1B
(VP2), 1C (VP3) and 1D (VP1)], we find that the
monophyletic SVDV cluster is nested within highly
supported purely CV-B5 clusters, whereas this is not
the case for the internal capsid region 1A (VP4). As
the internal capsid region is very short - and thus not
highly phylogenetically informative - the importance
of the associations of SVDV, including with CV-B5,
CV-A9, CV-B4 and echovirus serotype E30, found
here is difficult to assess. Of some note, is the pos-
ition of the newly sequenced Taiwanese 1983 CV-B5
isolate, 93083-3/Taiwan/83, which is closely related
to SVDV in all four capsid regions and also shows up
as closely related to SVDV in the 2A region. However,
downstream of the capsid the results of the analyses
change dramatically. Specifically, the SVDV cluster is
no longer nested within CV-B5 clusters, as was the
case for the 3 external capsid regions. For region 2A,
the SVDV cluster falls within a highly supported
cluster with Enterovirus B species sequences from
echovirus serotypes E6, E9, E25 and E30, as well as
CV-A9, and as mentioned, the 93083-3/Taiwan/83
CV-B5 isolate. However, the branch leading to the
SVDV cluster is quite long (relative to within SVDV
distances) in this analysis. This latter observation
also holds to some extent true for the 2C region,
where the closest sequence is an echovirus 6 from
Romania, with currently unknown year of isolation.
For the 3C region the closest sequences to SVDV fall
in an unsupported cluster (N.B. this is the only
analysis which used bootstrap for support)
including echovirus serotypes E9, E11 and E30 and
once again with a single CV-B5 isolate from this
study, this time a French 1984 isolate (84-6500/
France/84). Finally the 3D polymerase tree shows
the only result, where the closest (and highly sup-
ported sister) sequence to the SVDV cluster pre-
dates the 1966 discovery of SVD (Fig. 1). This 1963
Dutch CV-A9 isolate, Net/1/63 (acc. AF224653),
stems from a patient suffering from fever and con-
vulsions [55]. The sequence is 147 codons long and
differs from SVDV ITL/1/66 by two amino acids (one
being the initial codon of the sequence) and has a
(patristic) nucleotide similarity of 92.1% (amino
acid 98.6%). Another Dutch sample from the subse-
quent year of 1964, isolate Net/1/64 (acc.
AF166210) from a patient suffering from gastro-
enteritis and pharyngitis [55], falls as an unsup-
ported sister to SVDV and Net/1/63 (Fig. 1).
Taken together these results support a hypoth-
esis, stating that SVDV stems from a single recom-
binant origin involving two Enterovirus B serotypes,
CV-B5 and most likely CV-A9. Furthermore, SVDV
has remained monophyletic across the genome,
i.e. there is no supporting evidence of further recom-
bination with Enterovirus B serotypes, or any other
strains outside SVDV, following the emergence of
SVDV in swine.
Bayesian dating estimates
Thirty different Bayesian analyses were performed,
exploring five different tree priors and three different
molecular clocks on two separate genomic sections,
both free of recombination signals (Table 2).
Annotated trees from the highest marginal likeli-
hood analyses for each of the two analysed genome
sections and for both coalescent [39,40] and epi-
demiology birth-death tree prior analyses [43] were
constructed (Supplementary Fig. S3, corresponding
analyses in bold in Table 2). The difference in mar-
ginal likelihood in log(10) values between SS [50,51]
and PS [48,49,51] ranges from 0.0087 to 0.7714
across analyses (Table 2). With SS being the faster
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converging process of the two, we take this to indi-
cate, that the SS results can be used as a reliable
measure for marginal likelihood due to convergence
[56]. The difference in (SS) log(10) marginal likeli-
hood between the model with the highest marginal
likelihood and all other models (for the same gen-
omic section) is equivalent to a Bayes factor
[51,57,58] with the result given in the unit of bel.
From this, it is clear that all analyses using a strict
clock can be rejected outright—this is also sup-
ported by analysis of the ‘coefficient of variation’
parameter histograms in Tracer v. 1.5 [47]. Within
the coalescent analyses, the Bayesian skyline with an
uncorrelated lognormal relaxed clock, can reject all
other analysed (non-skyline) tree priors with a factor
of at least 2.27 bel for the protease-polymerase ana-
lyses and at least 5.33 bel for the within-capsid align-
ment. The best scoring epidemiology birth-death
models use an uncorrelated log-normal clock for
the within-capsid alignment and the relaxed
uncorrelated exponential clock for the protease-
polymerase alignment; these are both within 2 bel
of the best coalescent model (Bayesian skyline,
uncorrelated lognormal relaxed clock). Keeping to
the best coalescent skyline [39,40,42] and epidemio-
logical birth-death models [43] (in bold, Table 2), it is
clear from the dates, that there is a very good corres-
pondence between the estimates obtained from the
two different genomic sections. The 95% highest
posterior density interval (HPD) is much shorter
for the epidemiology birth-death analyses with the
oldest end not older than the beginning of 1959 for
the best model for either of the genomic sections.
Interestingly all four analyses support a scenario
where the date of the most recent common ancestor
of all analysed SVDV falls very close to the first iso-
lation of SVDV (Table 2 and Supplementary Figs. S3
and S4). The range of the medians for the four ana-
lyses is from February 1958 to November 1962, and
the combined range of their 95% HPDs on the age, is
from mid-1949 to May 1965.
DISCUSSION
A recombinant origin for an intra-specifically
recombining SVDV
Recombination between Enterovirus B species sero-
types has previously been well documented and re-
sults in a loss of monophyly (with regard to serotype)
outside of the capsid region [9,10,12]. Despite this,
we found no evidence for SVDV recombination with
other sampled viruses - although intra-specific
SVDV recombination was apparent. We hypothesise
this pan-genome SVDV monophyly may have been
assisted by the host species barrier between SVDV
and the Enterovirus B serotypes, with which the an-
cestral strains of SVDV would be expected to recom-
bine. Obviously this same species barrier has been
breached at one point—the origin of SVDV. It has
long been suspected that this involved a recombin-
ation event between CV-B5 and one (or more) other
unspecified Enterovirus B serotypes [7,8] (potentially
even another Enterovirus species). Because of these
very recombination dynamics, it is difficult to ascer-
tain which polymerase sequence was associated
with which serotype when going 50 years back in
time—except if one is fortunate enough to have
old sequenced samples. In this regard, the Dutch
1963 Net/1/63 isolate [55] is a remarkable find, both
because of its close similarity to (the oldest) SVDV,
and because it uniquely predates the first isolation of
SVDV with an age that falls perfectly within the un-
certainty intervals of our best-model dating ana-
lyses. Due to the spatiotemporal clustering of
sequences (even) outside the capsid, this clearly
suggests that SVDV arose as a recombinant between
two Enterovirus B serotypes, with the first being CV-
B5 and the second serotype most likely being CV-A9.
A recombination origin is further supported by the
overall contrast between the non-structural versus
structural section results in our maximum likelihood
tree analyses. The study [55], which generated the
partial polymerase sequence from Net/1/63 did
not analyse any other section than this downstream
of section 2A, thus we do not know what the relations
to SVDV are in the remainder of the 3rd genome
region (i.e. it explains why we do not see this strain
in the 3C analysis, assuming that recombination
occurred upstream of this).
Early isolations of SVDV in relation to the true
geographical origin
If the above findings are taken as a starting point for
a hypothesis for the origin of SVDV, then several
questions remain to be answered. If the ancestral
SVDV strain in pigs arose even a few years before
the first isolation, how did it go unnoticed until
October 1966? At SVDV’s original isolation on two
farms in Lombardy, Italy, the disease was taken to be
FMD due to clinical features being highly similar
between the two [1]. It was only upon failure to detect
FMD virus from the samples that further
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investigations were conducted, resulting in Nardelli
et al.’s [1] correct diagnosis of an enteroviral agent in
their September 1968 publication. Remaining
‘undercover’ as the agent of one of the most notori-
ous veterinary diseases might not intuitively seem
like an obvious way for a virus to have avoided dis-
covery, but it clearly depends on the prevalence of
the disease with which symptoms are shared, and
also the level of surveillance and sampling. As an
intriguing example, it can be seen (Supplementary
Table S3) that at around the time of the Netherlands
1963 CV-A9 Net/1/63 isolate, i.e. from about 1962
and continuing until 1966, outbreaks of FMD were in
the thousands in the country, whereas they were
orders of magnitude lower only a few years before
and after. This period fits not only with the age of the
sample but also our dating of the SVDV ancestor.
Under such conditions it is possible to imagine how
an unknown virus with highly similar clinical mani-
festation could be overlooked. Other factors affect-
ing such a scenario include which cell lines were
being used for passage in monitoring labs,
exemplified by FMDV being able to replicate in pri-
mary bovine thyroid cells, which is not the case for
SVDV. However, any vesicular disease occurring in
farm animals in Western Europe would be expected
to be investigated, and SVDV would thus not be ex-
pected to go undetected for long, except possibly in
the high incidence FMD settings mentioned earlier.
Therefore it is reasonable to consider whether the
more parsimonious explanation is simply that the
origin lies in an area where there was no monitoring,
or from where the results of monitoring have not
been reported. The most obvious candidate for this
is China. There is a complete lack of concurrent vet-
erinary information or samples from China, and yet
pig export patterns fit with several distinct introduc-
tions/occurrences of SVDV in Europe, Hong Kong
and other parts of Asia. For Europe this may fit with
the original isolated cases at the two farms in Italy,
but more clearly so with later cases in eastern
European countries, which were importing pig meat
from China during the Cold War. Examples of this
include SVDV in 1971 from a military farm in Plovdiv
Bulgaria, where the origin was reported as pig meat
from China, and where the BUL/1/71 strain is closely
related to a Hong Kong strain from the same year
(HKN/36/71). These strains are also related to sam-
ples from Odessa, Ukraine from 1972. Eastern
Europe would then have served as a stepping stone
for introductions into Western Europe as seems to
have been the case in 1972, where classic
epidemiology points to an introduction into
Poland spreading into Austria and from there on to
Italy, UK and eastern France. At the same time we
recognize Hong Kong, where several of the oldest
SVDV samples are from, as a major importer of pigs
from China, as well as China being a likely origin for
the 1973 introduction of SVDV into Japan. Thus,
China needs to be considered as a strong candidate
for the origin of SVDV.
The biological and the geographical origin of
SVDV
We also need to answer which events could have
facilitated this recombination event, and where.
There is no strong evidence to support whether re-
combination took place in humans or in pigs, but
given that the ancestral strains are hosted by
humans; it is the most parsimonious explanation
that the recombination also took place in a human.
Regardless of this, the most likely origin is a location
with a coincident high prevalence of CV-B5 and CV-
A9, at the appropriate time, and obviously where an
appreciable level of swine farming was taking
place—areas with early SVDV cases being the pri-
mary candidates. The distinct phylodynamics of
Enterovirus B serotypes are helpful in narrowing this
down. As already underlined in 1958 in the following
quote by Albert Sabin [59]:
‘Please remember that Coxsackie B5 represents
only one of more than 50 known viruses that may
compete for the intestinal tract of children and
their parents during the summer period. It is one of
the interesting epidemiological manifestations that
in one particular area one of these viruses can get
the inside track and somehow push most of the
others off.’
A particularly well-described example of this effect
of acquired immunity, involving CV-B5 and CV-A9, is
documented in Japan in 1960 and 1961 in connec-
tion with large outbreaks of aseptic (viral) meningi-
tis [60–62], which is a serious, and unfortunately not
uncommon clinical manifestation of several
Enterovirus B serotypes. The particularly interesting
thing about the 1960/1961 Japanese outbreaks in
the present context (in addition to the fact that
Japan is an early SVDV incidence country, although
outbreaks of disease were limited to November–
December 1973 and 1975) is that it is known that
no other major epidemic of CV-B5 occurred in Japan
until 1984 [63] and also, that no other CV-B5
epidemic had occurred for several years before
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[60–62]. This places the Japanese 1960/1961 CV-B5
and CV-A9 outbreak in a ‘time-bubble’ in perfect ac-
cord with the estimated origin of SVDV.
Interestingly, Japan is not the only early-incidence
SVDV location having CV-B5 and CV-A9 outbreaks
documented in 1960/1961. Hong Kong, where
SVDV was found in 1970 (Supplementary Table
S1) as the earliest location subsequent to the initial
isolations in Italy, also has a report of outbreaks of
aseptic (viral) meningitis-causing CV-B5 (generally
1960) and CV-A9 (generally 1961) amongst British
Service personnel, during the same years [64].
However, this particular report does not cover the
general Hong Kong population (leaving it up to the
reader to extrapolate to the true prevalence), also
there is overall a one season time separation be-
tween the two strains in this report [64]. The alluring
aspect of large aseptic meningitis outbreaks as a
facilitating factor lies not only in the common biol-
ogy with SVDV, but also in the simple fact that the
higher the prevalence of the involved strains, the
higher the risk of co-infection, recombination and
subsequent anthroponotic emergence in swine will
have been. This brings us to the fact, that of the three
main aspects of the origin of SVDV, the biological,
the geographical and the temporal—the geograph-
ical remains the most difficult to answer. Previous
studies have pointed the finger in the direction of
Hong Kong as the most likely location for an origin
[8]. Our analyses (not shown) are in agreement with
prior results showing that SVDV has been imported
to Europe from Asia (from the 1970s and forward)
[8], subsequent to the initial isolation in Italy in 1966,
as mentioned above. However, we do not find that
an origin in Europe can be categorically ruled out.
The finding of the Dutch Net/1/63 strain as the
closest sequence to SVDV in the polymerase region
illustrates this, even if it seems to be negated by the
almost vanishing historical incidence of SVDV in the
Netherlands (also in later FMD-free years
(Supplementary Tables S1 and S3)). The original
Nardelli article [1] states that the two 1966 affected
Italian farms ‘had received pigs for fattening from a
common source’. The elusive nature of this ‘com-
mon source’ in the literature is quite frustrating, but
the fact that they are received ‘for fattening’ could
imply that it is not a very distant supplier. Strictly
speaking, the case is still that we only know that
SVDV has an origin in East Asia, most likely China,
or potentially in Europe. The best way to specify this
further (besides successful tracking of the quote
from the Nardelli article [1]), would be to obtain
historical samples from the type of outbreaks and
period described earlier, sequence them, and per-
form phylogenetic analyses similar to the ones
found in this study.
CONCLUSIONS AND IMPLICATIONS
It needs to be reiterated, that the recombinant na-
ture of the Enterovirus B serotypes strongly affects
phylogenetic inference between serotypes for gen-
omic sections outside those, which determine the
serotype itself. This means that the further isolates
are separated in time and space, the more likely they
are to be non-monophyletic in non-structural re-
gions with regards to their serotype designation.
Thus, it cannot be outright rejected, that the Net/
1/63 CV-A9 isolate has a genome section, which a
few years previously was circulating in a (SVDV
related) CV-B5 (or other serotype) strain. What we
do know is that the sequence was fit in a CV-A9 sero-
type in 1963 and that a very closely related sequence
was fit in a SVDV serotype in 1966. Given this, we
conclude that a CV-B5 and CV-A9 recombination
event leading up to the emergence of SVDV is a par-
simonious explanation for the SVDVs ancestry. It is
not clear if the recombination took place in humans
or pigs, but with humans as the natural host and
reservoir for the ancestral strains, humans are also
the most likely mixing vessel.
Our extensive sequence based analyses indicate
that SVDV arose within a narrow time-span around
1961. This result lends itself particularly well to sug-
gesting large coinciding outbreaks of viral meningitis,
caused by the ancestral serotypes, as documented in
the most likely geographical origin of East Asia, as the
historically contingent background for the emergence
of this significant veterinary disease.
These results not only have significant implica-
tions for the understanding of the natural history
of SVDV, but also represent an extraordinary ex-
ample of a founding event, and fundamental change
of ecology for this Enterovirus B serotype variant. The
genome-wide monophyly of SVDV with regards to its
closest relations, and across several decades, is
extraordinary within this highly recombinant spe-
cies. This means that the data and analyses given
here might well prove to describe the birth of a new
species.
supplementary data
Supplementary data is available at EMPH online.
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